The Netherlands Center for the Clinical advancement of Cell and Gene Therapies (NecstGen), situated in Leiden, comprises of a state-of-the-art facility and expert knowledge for the development, production, and commercialization of Cell and Gene Therapies. NecstGen helps academic and industrial Cell & Gene Therapy developers to enter the clinical stage by bringing together the required expertise from R&D, development, production, QA, QC and regulatory affairs in a brand new 4,000 m2 development & GMP manufacturing facility.
We enable the next generation of therapies by translating research programs into actionalbe health solutions for patients.
Our service offering:
A flexible Cell and Gene Therapy manufacturing model
- Full contract manufacturing services by our expert team for Cell Therapy and Viral Vector
- We manufacture Pre-clinical or toxicology study material, Phase I, Phase II clinical trial material
- GMP rental for any mammalian cell-based therapy type, including Cell and Viral Vector based therapies
- QC, QA, and QP services supporting our cleanroom rental
- Hybrid support on a flexible basis where our team compliments yours
Process and assay development for Cell Therapies and Viral Vector
- Process design and optimisation
- Scale-up to clinically relevant volumes
- Automation and closed processes
- Assay development for in-process controls, release- and potency tests
- Technology transfer in and out with flexibility in-mind for the future progress of your manufacturing
- Consultancy-based work to advise on decision making
Talk to NecstGen today about your needs for:
- Induced Pluripotent Stem Cells (iPSC)
- Chimeric Antigen Receptor T-Cells (CAR-T), Tumor Infiltrating Lymphocytes (TIL) T-Cell Receptor Modified T-Cells (TCR-T)
- Natural Killer (NK) Cells/CAR-NK Cells
- Dendritic Cells (DC)
- Mesenchymal Stromal Cells (MSC)
- Lentivirus (LV)
- Aden-associated virus (AAV)
- Oncolytic viruses
- Cleanroom rental for any mammalian cell-based therapy type
Company Details
- Employees
- 53
- Founded
- -
- Address
- Sylviusweg 62, Leiden,south Holland 2333 Be,netherlands
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- necstgen.com
- Keywords
- GMP, Cell therapy, Gene therapy, Viral vector production, iPSC, ESC, Process development, Regenerative medicine, ATMP, Viral Vector, Lentivirus, AAV, Oncolytic virus, Cleanroom rental, MSC, CAR-T, TIL, NK, DC.
- HQ
- Leiden, South Holland
Necstgen Questions
Necstgen's website is necstgen.com
Necstgen's LinkedIn profile is https://nl.linkedin.com/company/necstgen
Necstgen has
53 employees.
View email and phone details for 53
employees at Necstgen.
Necstgen's industry is
Pharmaceutical Manufacturing
Necstgen's top competitors are
Leyden Labs,
Proqr Therapeutics,
Leiden Bio Science Park,
Mimetas,
Vectory,
Halix,
Galapagos,
Batavia Biosciences,
Astraveus,
Uniqure.
Necstgen's categories are Pharmaceutical Manufacturing
Necstgen's founding year is 2020
